Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravitreal triamcinolone injection for macular anatomy in epiretinal membrane
IRCT20201120049450N4Phase 3Completed
- Sponsor
- Shiraz University of Medical Sciences
- Start
- Dec 2023
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, single-arm trial of triamcinolone in chorioretinal scar, sponsored by Shiraz University of Medical Sciences. Primary endpoint: Change in macular anatomy. Started Dec 2023; status: completed.
02
Drugs
triamcinolone
03
Conditions
chorioretinal scar
Beyond the preview
Go deeper on IRCT20201120049450N4.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20201120049450N4.